ctrl K

AI Score

Unlock

Lyra Therapeutics Inc. (LYRA)

AI Score

Unlock

0.21

-0.00 (-1.87%)

At close: Mar 03, 2025, 12:06 PM

Lyra Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	1.56M	1.36M	285K	n/a	n/a	1.24M
Cost of Revenue	n/a	1.07M	1M	95K	27K	n/a
Gross Profit	1.56M	296K	-716K	-95K	-27K	1.24M
Operating Income	-67.12M	-56.31M	-43.62M	-22.21M	-16.52M	-7.26M
Interest Income	4.5M	1.04M	102K	82K	213K	n/a
Pretax Income	-62.62M	-55.27M	-43.51M	-22.13M	-16.31M	-6.03M
Net Income	-62.68M	-55.28M	-42.41M	-22.05M	-16.09M	-6.03M
Selling & General & Admin	19.06M	17.56M	14.21M	9.69M	4.49M	3.53M
Research & Development	48.03M	38.8M	29.69M	12.52M	12.03M	4.97M
Other Expenses	n/a	1.32M	n/a	n/a	n/a	1.19M
Operating Expenses	68.68M	56.35M	43.9M	22.21M	16.52M	8.5M
Interest Expense	n/a	524K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	68.68M	56.35M	43.9M	22.21M	16.52M	8.5M
Income Tax	59K	13K	-1.1M	-82K	-213K	-1.23M
Shares Outstanding (Basic)	49.8M	30.24M	12.99M	8.59M	12.92M	6.27M
Shares Outstanding (Diluted)	49.8M	30.24M	12.99M	8.59M	12.92M	6.27M
EPS (Basic)	-1.26	-1.83	-3.27	-2.57	-1.25	-0.96
EPS (Diluted)	-1.26	-1.83	-3.27	-2.57	-1.25	-0.96
EBITDA	-65.25M	-53.92M	-42.61M	-22.11M	-16.49M	-7.18M
Depreciation & Amortization	278K	1.07M	1M	95K	27K	82K